If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrystal Amber Regulatory News (CRS)

Share Price Information for Crystal Amber (CRS)

Share Price is delayed by 15 minutes
Get Live Data
93.00    -0.50 (-0.53%)
Bid:
91.00
Ask:
95.00
Spread: 4.00 (4.396%)
Market Cap: £55.37m
CRS Live PriceLast checked at - London Stock Exchange

Intraday Crystal Amber Share Chart

Monthly Net Asset Value

6 Feb 2017 15:22

Crystal Amber Fund Limited - Monthly Net Asset Value

Crystal Amber Fund Limited - Monthly Net Asset Value

PR Newswire

London, February 6

 06 February 2017 

CRYSTAL AMBER FUND LIMITED(“Crystal Amber Fund” or the “Fund”)

Monthly Net Asset Value

Crystal Amber Fund announces that its unaudited net asset value (“NAV”) per share at 31 January 2017 was 218.51p (31 December 2016: 218.02p per share). 

The proportion of the Fund’s NAV at 31 January 2017 represented by the ten largest holdings, other investments and cash (including accruals), was as follows:

Top ten holdingsPence per sharePercentage of investee equity held
Hurricane Energy Plc75.013.0%
Grainger Plc34.43.4%
Northgate Plc33.84.9%
STV Group Plc20.113.9%
Leaf Clean Energy Co.14.029.9%
FairFX Group11.525.9%
Sutton Harbour Holdings Plc7.729.3%
Hansard Global Plc4.23.0%
Johnston Press Plc3.320.0%
Camellia Plc2.70.9%
Total of ten largest holdings206.7
Other investments16.3
Cash and accruals(4.5)
Total NAV218.5

For further enquiries please contact:

Crystal Amber Fund LimitedWilliam Collins (Chairman)Tel: 01481 716 000www.crystalamber.com

Allenby Capital Limited - Nominated AdviserDavid Worlidge/James ThomasTel: 020 3328 5656

Winterflood Investment Trusts - BrokerJoe Winkley/Neil LangfordTel: 020 3100 0160

Crystal Amber Advisers (UK) LLP – Investment AdviserRichard BernsteinTel: 020 7478 9080

Date   Source Headline
20th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Aug 20244:01 pmRNSHolding(s) in Company
16th Aug 20249:45 amRNSDirector/PDMR Shareholding
16th Aug 20249:43 amRNSTransaction in Own Shares and Total Voting Rights
15th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Aug 20247:00 amRNSExtension to Share Buyback Programme
31st Jul 20245:00 pmRNSTotal Voting Rights
31st Jul 202411:50 amRNSInvestee company update: Morphic Medical Inc.
31st Jul 202411:07 amRNSMonthly Net Asset Value
26th Jul 20244:06 pmRNSTransaction in Own Shares and Total Voting Rights
23rd Jul 20246:04 pmRNSTransaction in Own Shares and Total Voting Rights
3rd Jul 20245:42 pmRNSTransaction in Own Shares and Total Voting Rights
28th Jun 20245:15 pmRNSTotal Voting Rights
21st Jun 20245:00 pmRNSTransaction in Own Shares and Total Voting Rights
19th Jun 202410:07 amRNSMonthly Net Asset Value
18th Jun 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Jun 20244:49 pmRNSTransaction in Own Shares and Total Voting Rights
6th Jun 20245:15 pmRNSTransaction in Own Shares and Total Voting Rights
5th Jun 20245:43 pmRNSTransaction in Own Shares and Total Voting Rights
4th Jun 202412:11 pmRNSHolding(s) in Company
4th Jun 202412:11 pmRNSHolding(s) in Company
4th Jun 20247:00 amRNSMorphic Medical – FDA approval of study amendments
3rd Jun 20245:33 pmRNSTransaction in Own Shares and Total Voting Rights
3rd Jun 20247:00 amRNSTotal Voting Rights
31st May 20245:39 pmRNSTransaction in Own Shares
31st May 20247:00 amRNSTransaction in Own Shares
23rd May 20241:21 pmRNSMonthly Net Asset Value
23rd May 20247:00 amRNSExtension to Share Buyback Programme
22nd May 20247:00 amRNSTransaction in Own Shares
17th May 20245:49 pmRNSTransaction in Own Shares
3rd May 20246:22 pmRNSHolding(s) in Company
2nd May 202412:37 pmRNSHolding(s) in Company
1st May 20245:22 pmRNSTransaction in Own Shares
30th Apr 20245:37 pmRNSTotal Voting Rights
29th Apr 20243:26 pmRNSHolding(s) in Company
26th Apr 20245:27 pmRNSTransaction in Own Shares
25th Apr 20247:00 amRNSHolding(s) in Company
24th Apr 20244:00 pmRNSMonthly Net Asset Value
24th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20246:22 pmRNSTransaction in Own Shares
10th Apr 20249:34 amRNSTransaction in Own Shares
3rd Apr 20244:44 pmRNSMonthly Net Asset Value
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20241:30 pmRNSExtension to Share Buyback Programme
28th Mar 20246:01 pmRNSTotal Voting Rights
28th Mar 20247:00 amRNSHalf-year Report
27th Mar 20246:27 pmRNSTransaction in Own Shares
22nd Mar 20245:09 pmRNSTransaction in Own Shares
18th Mar 20245:29 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.